The Europe Sun
SEE OTHER BRANDS

The most trusted news from Europe

The Europe Sun: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Europe Sun.

Press releases published on April 28, 2025

Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France

Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France

MILAN, April 28, 2025 (GLOBE NEWSWIRE) -- Olon Group, a leading global pharmaceutical CDMO, announces the appointment of Jérôme Bédier as CEO of its French entities and Andrea Conforto as M…

46% of the most trusted US companies' employees reuse breached passwords

46% of the most trusted US companies' employees reuse breached passwords

Cybernews researchers analyzed the top 100 most trusted companies in America – including Nvidia, Costco, Apple, American Express, and others – and found that all of them had experienced data breaches, exposing critical cybersecurity weaknesses. Moreover, …

Vivopower's Tembo Secures Definitive Order from The Safari Collection in Africa

Vivopower's Tembo Secures Definitive Order from The Safari Collection in Africa

The Safari Collection is a world-renowned luxury safari company and owner of the Giraffe Manor This is another leading safari company in Africa that has placed an order with Tembo The first order was from Asilia Africa announced in February 2025 Tembo's …

DN Miner Expands Cloud Mining Services to XRP Holders, Unlocking New Passive Strategies Amid Growing User Demand

DN Miner Expands Cloud Mining Services to XRP Holders, Unlocking New Passive Strategies Amid Growing User Demand

London, UK, April 28, 2025 (GLOBE NEWSWIRE) -- Responding to surging user demand, DN Miner — a leader in AI-driven cloud mining — has officially expanded its platform to support XRP holders, offering them new passive strategies to grow their crypto …

Boehringer’s new zongertinib data demonstrate durable and clinically meaningful results in patients with HER2 (ERBB2)-mutant advanced NSCLC

Boehringer’s new zongertinib data demonstrate durable and clinically meaningful results in patients with HER2 (ERBB2)-mutant advanced NSCLC

Boehringer Ingelheim reported new and updated data from the Beamion LUNG-1 trial evaluating zongertinib in previously treated patients with HER2 (ERBB2)-mutant advanced non-small cell lung cancer (NSCLC). The data were featured in the official press …

Mark Your Calendars: Troller Cat’s Presale Goes Live on May 2

Mark Your Calendars: Troller Cat’s Presale Goes Live on May 2

London, UK , April 28, 2025 (GLOBE NEWSWIRE) -- Crypto enthusiasts, prepare yourselves: Troller Cat is about to hit the scene with a presale launch on May 2nd, 2025. Tapping into the electrifying meme coin space, this cat-themed token is quickly becoming …

NEURONES : Mise à disposition du Document d’Enregistrement Universel 2024

NEURONES : Mise à disposition du Document d’Enregistrement Universel 2024

INFORMATION PRESSE Rubrique : Document d’Enregistrement Universel 2024 Nanterre, le 28 avril 2025 Mise à disposition du Document d’Enregistrement Universel 2024 Le Document d’Enregistrement Universel 2024 a été déposé auprès de l’Autorité des Marchés …

Medicenna Presents Compelling Results from the ABILITY-1 Clinical Trial at the 2025 AACR Annual Meeting

Medicenna Presents Compelling Results from the ABILITY-1 Clinical Trial at the 2025 AACR Annual Meeting

Ten (10) patients have achieved an objective response (5 confirmed) when treated with MDNA11 alone or in combination with KEYTRUDA® (pembrolizumab) – all responders had advanced and/or metastatic cancers with resistance to immune checkpoint inhibitors (ICI …

Arqit delivers quantum-safe protection enhanced by confidential computing

Arqit delivers quantum-safe protection enhanced by confidential computing

LONDON, April 28, 2025 (GLOBE NEWSWIRE) -- Arqit Quantum Inc. (Nasdaq: ARQQ, ARQQW), a leader in quantum-safe encryption, has announced the delivery of quantum-safe protection enhanced by confidential computing; data protection that helps ensure no third …

SELLAS Unveils Breakthrough Preclinical Data Highlighting Efficacy of SLS009 in TP53 Mutated AML at the 2025 AACR Conference

SELLAS Unveils Breakthrough Preclinical Data Highlighting Efficacy of SLS009 in TP53 Mutated AML at the 2025 AACR Conference

NEW YORK, April 28, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …

Hudbay Signs Exploration Agreement with the Mosakahiken Cree Nation for the Talbot Deposit in Manitoba

Hudbay Signs Exploration Agreement with the Mosakahiken Cree Nation for the Talbot Deposit in Manitoba

TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) today announced the signing of an agreement with the Mosakahiken Cree Nation (“MCN”) on exploration activities in their traditional and ancestral …

Six Cybersecurity Products Achieve AV-Comparatives’ 2025 Anti-Tampering Certification

Six Cybersecurity Products Achieve AV-Comparatives’ 2025 Anti-Tampering Certification

AV-Comparatives has announced the results of its 2025 Defense Evasion (Anti-Tampering) Certification Test. INNSBRUCK, TYROL, AUSTRIA, April 28, 2025 /⁨EINPresswire.com⁩/ -- After rigorous testing against a wide array of sophisticated attack scenarios …

Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval

Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval

BERKELEY, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, today reviewed its major accomplishments of the …

80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting

80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - Evaxion presents striking EVX-01 data at the AACR Annual meeting

80% of EVX-01 vaccine targets triggered a tumor-specific immune response, a substantially higher frequency than what has been reported for other similar vaccine candidates The data underscores the precision of Evaxion’s AI-Immunology™ platform in selecting …

STMicroelectronics Announces Status of Common Share Repurchase Program

STMicroelectronics Announces Status of Common Share Repurchase Program

STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from Apr 22, 2025 to Apr 25, 2025 AMSTERDAM – April 28, 2025 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a …

ASML reports transactions under its current share buyback program

ASML reports transactions under its current share buyback program

ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average …

Rush Factory Oyj ja Sunborn International Holding Oy toteuttavat osakevaihdon; kaupankäynti osakkeilla Nasdaq First North Growth Market Finland -markkinapaikalla alkaa 29.4.2025

Rush Factory Oyj ja Sunborn International Holding Oy toteuttavat osakevaihdon; kaupankäynti osakkeilla Nasdaq First North Growth Market Finland -markkinapaikalla alkaa 29.4.2025

Rush Factory Oyj 28.4.2025 klo 15.00 EI JULKISTETTAVAKSI TAI LEVITETTÄVÄKSI SUORAAN TAI VÄLILLISESTI YHDYSVALTOIHIN, KANADAAN, UUTEEN-SEELANTIIN, AUSTRALIAAN, JAPANIIN, HONGKONGIIN, SINGAPOREEN TAI ETELÄ-AFRIKKAAN TAI MIHINKÄÄN MUUHUN VALTIOON, JOSSA …

Quanta Therapeutics Presents Late-Breaking Data for QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, at AACR Annual Meeting 2025

Quanta Therapeutics Presents Late-Breaking Data for QTX3544, an Oral G12V-Preferring Multi-KRAS Inhibitor, at AACR Annual Meeting 2025

- Preclinical data demonstrates synergy of QTX3544 with EGFR inhibitors, broadly enhancing anti-tumor activity - - Data supports ongoing Phase 1 clinical trial for QTX3544 as monotherapy and in combination with cetuximab in patients with KRASG12V mutations …

XRP ETF US Stock Listing: SAVVY MINING teaches you how to use XRP and DOGE to earn efficient and stable profits every day.

XRP ETF US Stock Listing: SAVVY MINING teaches you how to use XRP and DOGE to earn efficient and stable profits every day.

Washington, D.C., April 28, 2025 (GLOBE NEWSWIRE) -- XRP has taken a historic step! In April, the first 2x leveraged XRP ETF in the United States was officially listed on the NYSE Arca, providing short-term investors with higher income opportunities. As …

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer’s Drug

Silo Pharma Expands Intellectual Property Portfolio with Patent Application for Exclusively Licensed Alzheimer’s Drug

SARASOTA, FL, April 28, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced the filing of a patent …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service